Evidence map›Paper›PMID 27825049›Full record

ArticleMolecular immunology2016

Crystal structure of a polypeptide's C-terminus in complex with the regulatory domain of ER aminopeptidase 1.

Lufei Sui, Amit Gandhi, Hwai-Chen Guo

Abstract read
In one paragraph

Article in Molecular immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lufei SuiDepartment of Biological Sciences, University of Massachusetts Lowell, 1 University Avenue, Lowell, MA 01854, USA.
Amit GandhiDepartment of Biological Sciences, University of Massachusetts Lowell, 1 University Avenue, Lowell, MA 01854, USA; Current Address: Brigham and Women's Hospital/Harvard Medical School, 20 Shattuck Street Boston, MA 02115, USA.
Hwai-Chen GuoDepartment of Biological Sciences, University of Massachusetts Lowell, 1 University Avenue, Lowell, MA 01854, USA. Electronic address: HwaiChen_Guo@uml.edu.

Funding

Case Center for Synchrotron BiosciencesP30EB009998 · NIBIB · CASE WESTERN RESERVE UNIVERSITY · PI CHANCE, MARK R · 2009 to 2018
$8.4M
Towards Structural Studies of Aminopeptidases in Antigen ProcessingR21AI068831 · NIAID · UNIVERSITY OF MASSACHUSETTS LOWELL · PI GUO, HWAI-CHEN · 2009 to 2010
$316k
Structural studies on an aminopeptidase inside the endoplasmic reticulumR03AI078134 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GUO, HWAI-CHEN · 2008 to 2009
$163k
NIAID NIH HHS R03 AI078134NIAID NIH HHS R21 AI068831NIBIB NIH HHS P30 EB009998
6 · The paper itself

Abstract

Endoplasmic reticulum aminopeptidase 1 (ERAP1) is involved in the final processing of peptide precursors to generate the N-termini of MHC class I-restricted epitopes. ERAP1 thus influences immunodominance and cytotoxic immune responses by controlling the peptide repertoire available for cell surface presentation by MHC molecules. To enable this critical role in antigen processing, ERAP1 trims peptides by a unique molecular ruler mechanism that turns on/off hydrolysis activity in a peptide-length and -sequence dependent manner. Thus unlike other aminopeptidases, ERAP1 could recognize both the N- and C-termini of peptides in order to read the substrate's length. To exemplify and validate this molecular ruler mechanism, we have carried out crystallographic studies on molecular recognition of antigenic peptide's C-terminus by ERAP1. In this report, we have determined a 2.8Å-resolution crystal structure of an intermolecular complex between the ERAP1 regulatory domain and a natural epitope's C-terminus displayed in a fusion protein. It reveals the structural details of peptide's C-termini recognition by ERAP1. ERAP1 uses specificity pockets on the regulatory domain to bind the peptide's carboxyl end and side chain of the C-terminal anchoring residue. At the same time, flexibility in length and sequence at the middle of peptides is accommodated by a kink with minimal interactions with ERAP1.

Indexed as

AminopeptidasesAnimalsAntigen PresentationCrystallography, X-RayHumansMinor Histocompatibility AntigensPeptidesProtein ConformationAminopeptidasesERAP1 protein, humanMinor Histocompatibility AntigensPeptidesAntigen-ERAP1 interactionsComplex structureC-terminus recognitionEndoplasmic reticulum aminopeptidase 1ERAP1 regulatory domainMolecular ruler mechanism

Identifiers

PMID27825049
PMCPMC5148704

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.